Generate Biomedicines, Inc.
GENB
$15.64
$0.614.06%
NASDAQ
| 06/30/2026 | 03/31/2026 | 06/30/2025 | |||
|---|---|---|---|---|---|
| Revenue | 6.31M | 7.22M | 10.13M | ||
| Total Other Revenue | -- | -- | -- | ||
| Total Revenue | 6.31M | 7.22M | 10.13M | ||
| Cost of Revenue | 64.33M | 57.81M | 59.74M | ||
| Gross Profit | -58.02M | -50.59M | -49.61M | ||
| SG&A Expenses | 13.60M | 13.52M | 10.55M | ||
| Depreciation & Amortization | -- | -- | -- | ||
| Other Operating Expenses | -- | -- | -- | ||
| Total Operating Expenses | 77.93M | 71.34M | 70.28M | ||
| Operating Income | -71.61M | -64.11M | -60.15M | ||
| Income Before Tax | -67.20M | -61.69M | -56.70M | ||
| Income Tax Expenses | 53.00K | 28.00K | 44.00K | ||
| Earnings from Continuing Operations | -67.26M | -61.71M | -56.74M | ||
| Earnings from Discontinued Operations | -- | -- | -- | ||
| Extraordinary Item & Accounting Change | -- | -- | -- | ||
| Minority Interest in Earnings | -- | 268.00K | 4.31M | ||
| Net Income | -67.26M | -61.45M | -52.43M | ||
| EBIT | -71.61M | -64.11M | -60.15M | ||
| EBITDA | -66.19M | -63.04M | -54.73M | ||
| EPS Basic | -0.52 | -1.07 | -1.94 | ||
| Normalized Basic EPS | -0.33 | -0.59 | -0.94 | ||
| EPS Diluted | -0.52 | -1.07 | -1.94 | ||
| Normalized Diluted EPS | -0.33 | -0.59 | -0.94 | ||
| Average Basic Shares Outstanding | 128.24M | 64.87M | 33.00M | ||
| Average Diluted Shares Outstanding | 128.24M | 64.87M | 33.00M | ||
| Dividend Per Share | -- | -- | -- | ||
| Payout Ratio | -- | -- | -- | ||